HOME >> BIOLOGY >> NEWS
HSUS news conference

HSUS to launch effort to end research animal pain and distress at Washington news conference

WHO:
Andrew Rowan, Ph.D., senior vice president, The Humane Society of the United States (HSUS)

Martin Stephens, Ph.D., vice president, Animal Research Issues, The HSUS

Alan Goldberg, Ph.D., director, The Center for Alternatives to Animal Testing, Johns Hopkins University

Barbara Orlans, Ph.D., professor, The Kennedy Institute of Ethics, Georgetown University

Victoria Hampshire, VMD, director, Advanced Veterinary Applications

WHAT:
News conference to launch The HSUS' efforts to end pain and distress in research animals by the year 2020.The HSUS will release a report documenting that substantial numbers of animals used in research in the United States endure pain and distress that is neither reported nor alleviated despite federal Animal Welfare Act mandates. The report also contains The HSUS' blueprint for ending pain and distress in research animals over the next 20 years.

Other panel participants will discuss the legislative framework for addressing pain and distress, public concern on this issue, the recognition and alleviation of pain and distress, and problems with the existing system for reporting pain and distress.

WHEN:
Thursday, April 27, 2000 10:00 a.m.

The week of April 23 is World Week for Animals in Laboratories

WHERE:
First Amendment Room National Press Club Washington, DC

A light breakfast will be served.


'"/>

Contact: Rachel Querry
rquerry@hsus.org
301-258-8255
Humane Society of the United States
24-Apr-2000


Page: 1

Related biology news :

1. IBD (Crohns/ulcerative colitis) conference adds 18 speakers; APS meeting starts Thursday
2. Rising childhood leukaemia incidence prompts conference
3. Society for conservation biology conference
4. The protection of human subjects in gene transfer research explored at conference in July
5. International research conferences at the Villa Vigoni
6. National nanotech expert to address UW-Madison conference
7. Landmark conference for United Nations on human cloning and stem cell research
8. European Society of Human Reproduction and Embryology conference - June 2004
9. First DFG research conference in the USA
10. Jan. 23-26 conference in Oakland, Calif., to discuss aneuploid theory of cancer
11. UC San Diego to host two-day conference on sustainable development Dec. 11 & 12

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: HSUS news conference

(Date:7/8/2015)... LAKES , N.J. and NEW YORK ... Company) and Guidepoint today announced BD ... start-up healthcare companies with free access to Guidepoint,s expert ... several start-ups that are developing cutting-edge technologies to improve ... a dedicated Guidepoint research manager, each start-up entrepreneur will ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
(Date:7/30/2015)... ... July 30, 2015 , ... ... a field clinical study of its canine osteoarthritis stem cell product, currently under ... (Kansas City, KS) and will be marketed in the US by Aratana. This ...
(Date:7/30/2015)... 30, 2015   Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients ... reported financial results for the second quarter 2015. ... we remain on track to achieve our commercial and ... Officer of the Company. "Since our last quarterly earnings ...
(Date:7/30/2015)... , July 30, 2015 Ascendis Pharma ... that applies its innovative TransCon technology to address ... results from a six-month Phase 2 study to ... Growth Hormone in 53 treatment-naïve, pre-pubertal children with ... are extremely pleased with the top-line results from ...
(Date:7/30/2015)... 2015  Discovery Laboratories, Inc. (Nasdaq: DSCO ... second $1.0M tranche under a previously awarded Phase ... at up to $3.0 million to support continued ... a potential medical countermeasure to mitigate acute and ... an initial $1.0 million under this grant in ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
Cached News: